Watt, Melissa H.
Minja, Linda M.
Barabara, Mariam
Mlay, Pendo
Stephens, Maya J.
Olomi, Gaudensia
Mlay, Janeth
Marchand, Virginie
Mmbaga, Blandina T.
Hanson, Olivia R.
Cohen, Susanna R.
Funding for this research was provided by:
National Institutes of Health (R21 TW012001, D43 TW010543)
Article History
Received: 17 November 2022
Accepted: 1 March 2023
First Online: 16 March 2023
Declarations
:
: The original protocol (Version 1) was approved by the ethical review committees in August 2021. The published protocol is current as of August 24, 2022. Protocol modifications will be submitted to the relevant ethical review committees and modified on clinicaltrials.gov.
: Dr. Melissa Watt (Utah)Intermountain Healthcare Department of Population Health SciencesSpencer Fox Eccles School of MedicineUniversity of Utah295 Chipeta WaySalt Lake City, UT 84102melissa.watt@utah.edu Dr. Blandina Mmbaga (KCMC)Kilimanjaro Clinical Research Institute, Moshi, Tanzania+255 27 2754377/80b.mmbaga@kcri.ac.tz
: The study has been approved by the ethical review committees at the University of Utah (Protocol 00143918), Kilimanjaro Christian Medical Center (Protocol 2056), and National Institute for Medical Research in Tanzania (Protocol 3853). All procedures performed in studies involving human participants are in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. (University of Utah 00143918, Kilimanjaro Christian Medical Centre 2516, National Institute for Medical Research, Tanzania 3853). Informed consent is obtained from all individual participants included in the study.
: Not applicable.
: The authors declare that they have no competing interests.